US$ 24.40
what is glp-1 drugs medications get at the heart of addiction: study – WashU Medicine Patients' Use GLP-1 Drugs for
Description
The failure of behavioral interventions to produce sustained weight loss in an overwhelming majority of cases underscores the importance of identifying novel therapeutic strategies to promote and sustain reductions in food intake and body weight
10.3389/fimmu.2019.01050 Summary Keywords T2DM, incretin effect, DPP-4 enzyme, DPP-4 inhibitors, (GLP)-1, insulin Citation Saini K, Sharma S and Khan Y (2023) DPP-4 inhibitors for treating T2DM - hype or hope

Both groups were adjusted for baseline differences using propensity score weighting (eTable 1 in Supplement 1), so differences at follow-up could be attributed to the treatment

Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes

Jrime J, Kums T, Jrime T
